Atopic dermatitis (AD) and psoriasis are chronic inflammatory skin diseases with distinct but partly overlapping immune pathways. Psoriasis and psoriasiform eruptions have been reported during targeted treatment for AD, most frequently with dupilumab, which inhibits interleukin (...
Open access
Research Article10.9734/ajmpcp/2026/v9i2503
Background: Lichen planus (LP) is a T-cell-mediated inflammatory disorder involving the skin, mucosae, nails and hair follicles. Published observations of LP and lichenoid reactions during interleukin-17 (IL-17) inhibition pose diagnostic and causality challenges, particularly be...
Open access
Research Article10.9734/ajrdes/2026/v9i1193
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disorder frequently diagnosed in older adults. The expanding use of sodium–glucose cotransporter 2 (SGLT2) inhibitors makes the assessment of suspected medication-associated BP clinically relevant. This narrative re...
Open access
Research Article10.9734/ajrdes/2026/v9i1191